Children are the forgotten drug? That was the theme of a symposium, organized by the national Union of the pharmaceutical industry on October 5, 2000. Unfortunately, it can only respond positively to this question. Because the inadequate packaging and medicines designed for adults today are the common lot of the majority of the young patients. Where hope to tackle this problem by setting up a European regulatory urging industrialists to make paediatric drugs.
Large capsules difficult to swallow, tablets to be break into small pieces or crushed, it is every day that pediatricians must “tinkering” solutions to enable their small patients to take care of. When they do not, prescribe non-authorisation for placing on the market, a drug normally reserved for adults – with all the consequences you can imagine legally – when a complication occurs. In total, “three-quarters of drugs used in children and more than 90% of those who are employed in a hospital emergency have not been evaluated home”, says Annie Wolf, responsible for the Mission of orphan and paediatric medicines to the Ministry of employment and solidarity. Continue reading “Drug abuse intervention”